BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Servier 

22 Rue Garnier

Neuilly Sur Seine    92200  France
Phone: N/A Fax:


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





 Company News
miRagen Therapeutics Achieves First Milestone in Strategic Alliance With Servier 5/23/2013 10:59:42 AM    More...
Afraxis, Inc. and Servier Announce a Collaboration on ESP Platform for Drug Discovery in Central Nervous System Disorders 4/30/2013 10:37:38 AM    More...
European Medicines Agency Staff Push to Restrict Servier Osteoporosis Drug 4/15/2013 8:12:21 AM    More...
French Regulator Investigated Over Servier Scandal 3/22/2013 7:33:40 AM    More...
Vernalis PLC (VNLPY.PK) and Servier Extend Oncology Collaboration 3/6/2013 2:48:37 PM    More...
Galapagos NV (GLPG.BR) Receives $9.7 Million in Servier Alliances 3/6/2013 7:22:30 AM    More...
Vernalis PLC (VNLPY.PK) and Servier Achieve Research Milestone in Third Oncology Collaboration 1/7/2013 11:37:21 AM    More...
Servier Founder Faces Manslaughter Charges 12/13/2012 7:51:18 AM    More...
XOMA Corporation (XOMA) Announces Servier Has Initiated a Proof-of-Concept Gevokizumab Study in Patients With a History of Acute Coronary Syndrome 11/29/2012 10:34:42 AM    More...
Florey Neurosciences Institutes and Servier to Collaborate on a Novel Target for Alzheimer's Disease 10/15/2012 11:15:41 AM    More...
1234567